EXOZ Invizyne Technologies Total Asset Value of Company

EXOZ (Invizyne Technologies, Inc.) - company brandmark

eXoZymes Inc (EXOZ) is at the peak of scientific and technical development, creating eco-friendly synthesis systems for high-value substances. The complexity of implementing such laboratory methodologies into the industry, combined with patent protection, creates a powerful barrier to entry for competitors. Total assets amount to 8.83, confirming the business's strong pricing power driven by its unique cell-free platform, as reflected in the accompanying price chart.

EXOZ (eXoZymes Inc) Company Total Assets history from 02/13/2025 to 10/29/2026
Manufactured products of eXoZymes Inc

Developing innovative cell-free enzyme systems requires significant resources, making R&D capitalization critically important for eXoZymes Inc (EXOZ). The dynamics of total assets, calculated inversely via ROA, reflect the actual speed of business scaling and the efficiency of liability management. This metric combines equity and debt, demonstrating the company's aggregate resource base. By analyzing the history of balance sheet assets, an investor can assess the stability of the financial foundation prior to the launch of breakthrough products.

Key competitors

Total Asset Value of Company HLN (haleon.com)|Aggregate Company Assets Kenvue|Verona Pharma PLC - Total Asset Value of Company|Company Total Assets MENS|LGND (Ligand Corp) - Aggregate Asset Value|Company Total Assets AMRX (Amneal Pharmaceuticals)|Company Total Assets perrigo.com PRGO|ALVO - Aggregate Company Assets|Aggregate Asset Value LQDA (Liquidia Corp)|Galapagos Genomics (GLPG) - Aggregate Company Assets|Cumulative Company Assets ANI Pharmaceuticals Corp|MNKD (MannKind Corporation) - Company Total Assets|Company Total Assets amphastar.com|Cumulative Company Assets PCRX (Pacira BioSciences, Inc.)|SPRY (ARS Pharmaceuticals Inc) - Aggregate Asset Value|Aggregate Company Assets Theravance TBPH|Aquestive Corp (AQST) - Company Assets|SCPH: Cumulative Company Assets|Tectonic Therapeutic, Inc. - Aggregate Business Assets|TNXP: Company Total Assets|China SXT Pharmaceuticals, Inc. - Aggregate Asset Value|EPRX (Eupraxia Pharmaceuticals, Inc.) - Company Total Assets|Company Assets BioHarvest Sciences Inc BHST|Aggregate Company Assets Oramed Pharmaceuticals (ORMP)|ENTX (enterabio.com) - Aggregate Asset Value|Company Total Assets HYFT (MindWalk Holdings Inc.)|ABVC BioPharma Inc. (ABVC) - Company Assets|CPIX: Cumulative Company Assets|QNTM (Quantum BioPharma Corp) - Total Business Assets|FibroGen, Inc. (FGEN) - Aggregate Company Assets|Company Assets telomirpharma.com (TELO)|Cumulative Company Assets RANI|Synergy CHC Corporation - Total Asset Value of Company|Cumulative Company Assets RLYB (Rallybio Corporation)|LEXX - Company Assets|Aggregate Company Assets Pulmatrix, Inc. PULM|PTHL - Cumulative Company Assets|Aptorum - Company Total Assets|Company Assets Lyra Therapeutics Inc.|Impact BioMedical (IBO) - Aggregate Company Assets|TNFA - Company Total Asset Base|Cumulative Company Assets YCBD|PRFX: Aggregate Asset Value|Company Total Assets CYTO|Company Total Asset Base Lipella Pharmaceuticals Inc|Aggregate Company Assets Optinose OPTN|PIRS: Total Business Assets|Procaps Group S.A. - Company Total Assets|petrospharma.com (PTPI) - Cumulative Company Assets|QLI: Company Total Assets|Company Assets Acelyrin Inc. (SLRN)|Cumulative Company Assets TFFP